SCHEMBL5783771

SCHEMBL5783771

CC(C)(C)OC(=O)N1CCC[C@@]2(C=C(OS(=O)(=O)C(F)(F)F)CO2)[C@@H]1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 12/20 0.40
▸ NR1H3 Q13133 10/20 0.40
▸ HCRTR2 O43614 1/20 0.38
▸ RXRA P19793 3/20 0.37
▸ RORC P51449 2/20 0.35
▸ KLK7 P49862 1/20 0.35
▸ WNT3 P56703 2/20 0.34
▸ SFRP1 Q8N474 2/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ GPR119 Q8TDV5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784586 0.81 TACR1 (0.51) NR1H2NR1H3HCRTR2RXRA
SCHEMBL5784791 0.80 KLK7 (0.41) NR1H2NR1H3HCRTR2RXRARORC
SCHEMBL6075001 0.76 NR1H2 (0.43) NR1H2NR1H3HCRTR2RXRARORC
SCHEMBL5786819 0.76 NR1H2 (0.43) NR1H2NR1H3HCRTR2RXRARORC
SCHEMBL5788553 0.75 KLK7 (0.41) NR1H2NR1H3HCRTR2RXRAKLK7
SCHEMBL8163041 0.75 KLK7 (0.41) NR1H2NR1H3HCRTR2RXRAKLK7
SCHEMBL7922384 0.74 TACR1 (0.35) NR1H2NR1H3RXRAKLK7WNT3
SCHEMBL7916867 0.73 JAK3 (0.43) NR1H2NR1H3RXRA
SCHEMBL8153805 0.73 NR1H2 (0.41) NR1H2NR1H3HCRTR2RXRAKLK7
SCHEMBL8157924 0.73 NR1H2 (0.41) NR1H2NR1H3HCRTR2RXRAKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929554-B1 SPIRO-AZACYCLIC DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS MERCK SHARP & DOHME (GB) 2006-03-15 — — EP disclosed
US-6046195-A Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists MERCK SHARP & DOHME LTD. (GB) 2000-04-04 — — US disclosed
Send feedback